Polaris wins largest ever pharmaceutical commercial compliance technology project

Share Article

Three global pharmaceutical companies have invested in Polaris’ Global Compliance Platform in recent months.

This week, Polaris finalized its third major deal of 2016, as it kicked off the largest contract in life science compliance technology history.

Three life science manufacturers have selected the Polaris Global Compliance Platform (GCP) to manage Healthcare Professional (HCP) and Healthcare Organization (HCO) interactions, from needs assessment through to transparency reporting. Using Polaris’ GCP will allow these companies to compliantly automate interactions such as: advisory boards, consulting arrangements, speaker programs, grants & donations, investigator research and other HCP/HCO interactions. The processes covered include needs assessment, HCP/O identification & due diligence, approvals, contracting, regulatory notification (such as DMOS), reconciliation and finally transparency reporting (e.g. Sunshine Act, US State Rules, EFPIA, France, etc.).

The fully hosted Software as a Service (SaaS) solution can integrate with all major corporate systems, such as ERPs (SAP, Oracle, JDE, etc.), Customer Masters, CRM tools, Single Sign-On and others. Polaris’ dedicated worldwide implementation and support teams ensure that the systems are implemented properly and that clients are completely satisfied.

“When I founded Polaris in 2001, I had a sense that significant changes were on the horizon for the worlds of healthcare and compliance. By partnering with Marc Eigner and brilliant experts in legal, technology and software, we have been able to stay on the cutting edge of healthcare compliance, consistently delivering innovative solutions to the tough global challenges the industry faces,” said Andy Bender, Founder and President of Polaris.

“Experts from the Polaris team and I will be available to discuss these solutions at three upcoming conferences. First, at the Medical Device Compliance Congress in Chicago on April 20th. April 26th and 27th, we will be at the Pharmaceutical Compliance Congress in Washington DC. May 10-12th, Polaris representatives will be attending the International Pharmaceutical Compliance Congress in Warsaw, Poland. We look forward to sharing our insights and compliance solutions with the life science industries,” said Marc Eigner, Co-founder and Senior Partner of Polaris.

About Polaris
Polaris is the global authority on life science compliance, delivering innovative, expert consulting and comprehensive, best-in-class software and technology solutions, compliance management systems and business process outsourcing to the world’s most recognized pharmaceutical, biotech and medical device companies. Learn more at http://www.polarismanagement.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Arbini
+1 917-568-4288
Email >
Follow >
Like >

Follow us on
Visit website